Commonwealth Equity Services’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Commonwealth Equity Services's CASC Position: Q1 2018 in Review

Commonwealth Equity Services sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 15,514 shares — an estimated $57K sold.

Commonwealth Equity Services first reported a position in CASC in Q4 2017 and held it in 1 quarter. The position peaked at $57K in Q4 2017. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

• Commonwealth Equity Services reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
• Commonwealth Equity Services sold 15,514 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $57K.
• Commonwealth Equity Services first reported a position in Cascadian Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
• Commonwealth Equity Services's Cascadian Therapeutics, Inc. position peaked at $57K in Q4 2017.
• 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on Commonwealth Equity Services's 13F filing for Q1 2018, filed 14 May 2018.